Fund BasicsSee More
- Fund Family Innovation Shares LLC
- Assets Under Management 162,486,000
- Shares Outstanding, K 8,850
- 60-Month Beta 1.84
- Price/Earnings ttm 0.00
- Annual Dividend & Yield 0.45
- Most Recent Dividend 0.048
- Management Fee 0.70%
|Period||Period Low||Period High||Performance|
| || |
-4.33 (-19.07%)since 02/08/21
| || |
+4.97 (+37.09%)since 12/08/20
| || |
+9.21 (+100.55%)since 03/06/20
CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) ("Clever Leaves" or the "Company"), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today it has...
Here we discuss some ETFs that can lend investors exposure to the thematic investing trends in 2021.
After promoting GameStop (GME) and Silver, Reddit's discussion has now popularized marijuana stocks like Sundial Growers (up 78.8% on Feb 10) and Tilray (up more than 50% on Feb 10).
Scotiabank joins the Hockey Diversity Alliance to support its mission to eradicate systemic racism in Hockey
Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock that has strengthened the bullish case for the cannabis industry.
A few top ETF stories ruled the month of January and deserve a close look in February.
As Joe Biden prepares to take over the U.S. Presidential reins, the cannabis industry in the U.S. is basking in optimism. Following indications by New York’s governor that he will support the legalization...
Let's look at some ETF areas that are expected to perform well as Democrats take control of the U.S. Senate.
Cannabis stocks and ETFs jumped following the Democratic victories in Georgia's two runoff elections that have spurred hopes for near-term decriminalization.
|3rd Resistance Point||19.91|
|2nd Resistance Point||19.46|
|1st Resistance Point||18.91|
|1st Support Level||17.91|
|2nd Support Level||17.46|
|3rd Support Level||16.91|